FDA Inspection 1154972 — Medley Pharmaceuticals Limited
The FDA completed an inspection of Medley Pharmaceuticals Limited on December 14, 2018 in Daman. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- December 14, 2018
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Daman (India)
Additional Details
Mutual Recognition Agreement (MRA)